They’re necessary, but not necessarily nice.
And every med has its own side-effects.
Just as different people experience different difficulties.
But here‘s the low-down on some possible side-effects.
As an orphan drug, you can see why epilepsy isn’t way up front in the funding department.
But, miraculously, there are 7 new drugs that have come down the line.
Here’s a brief summary of each…
On October 24, 2012 the FDA approved Perampanel as an adjunct treatment for refractory partial-onset seizures in patients with epilepsy aged 12 years and older. A step forward for us all. Here’s why…
Most Recent Posts
Top posts
About the author
I've been a professional copywriter for over 35 years. I also had epilepsy for decades. My mission is advocacy; to increase education, awareness and funding for epilepsy research. Together, we can make a huge difference. If not changing the world, at least helping each other, with wisdom, compassion and sharing.
Epilepsy Talk